Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial

Overview of attention for article published in Frontiers in Medicine, May 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#8 of 7,366)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 2580 X posts from 1810 X users, with an upper bound of 2,892,405 followers.

RT @kkkkkkk777: 北里大学の新型コロナに対するイベルメクチンの治験が論文化された❣️ https://t.co/DVDZzVKc0o 問題点は既出❣️ https://t.co/h9OhxAWdB9 δ株のウイルス量のピークは発症後3-5日と考えられ、発症…

@99_polieco_sub イベルメクチンは寄生虫用の薬なので。コロナには有効ではなかった(プラセボとの有意差が無かった)と論文が出ています↓ https://t.co/Ad8t1rLYb3

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2576 additional X posts.